fig1

Management of patent foramen ovale-associated stroke: a review of closure <i>vs.</i> medical therapy

Figure 1. The prevalence of CS or ESUS in all ischemic stroke patients and the therapeutic options for the prevention of the recurrence of ischemic stroke in these patients with PFO-related stroke. Figure 1 was drawn by the authors using Microsoft PowerPoint. CS: Cryptogenic stroke; ESUS: embolic stroke of undetermined source; PFO: patent foramen ovale.

Ageing and Neurodegenerative Diseases
ISSN 2769-5301 (Online)

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/